Development of Therapeutic Products for Marburg Virus
Development of Therapeutic Products for Marburg Virus
批准号:
10787970
负责人:
M Javad Aman
金额:
$169.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-17 至 2025-12-16
关键词:
Advanced DevelopmentCategoriesChemistryClinicalDevelopmentEmerging Communicable DiseasesMarburgvirusNational Institute of Allergy and Infectious DiseasePathway interactionsefficacy evaluationmanufacturepre-clinicalpriority pathogenproduct developmentresearch and developmentsafety assessmenttherapeutic candidatetherapeutic development
中文摘要
支持针对NIAID A、B和C类优先病原体或新出现的传染病的有前途的候选治疗药物的高级开发。将支持的研究和开发活动将允许候选治疗产品在产品开发过程中取得进展,包括临床前和IND支持开发活动、化学优化/开发、GMP制造以及临床安全性和有效性评估。
英文摘要
To support the advanced development of a promising candidate therapeutic for NIAID Category A, B, and C Priority Pathogens or emerging infectious diseases. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prophylactic Immunotherapy for Marburg Virus Disease Outbreak Control
-
批准号:10697211
-
项目类别:
-
资助金额:$98.62万
-
财政年份:2023
-
负责人:M Javad Aman
-
依托单位:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
-
批准号:10761372
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2023
-
负责人:M Javad Aman
-
依托单位:
Immunotherapy of MRSA Osteomyelitis
-
批准号:10404061
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2021
-
负责人:M Javad Aman
-
依托单位:
Immunotherapy of MRSA Osteomyelitis
-
批准号:10595669
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2021
-
负责人:M Javad Aman
-
依托单位:
Development of Therapeutic Products for Marburg Virus
-
批准号:10455345
-
项目类别:
-
资助金额:$174.94万
-
财政年份:2021
-
负责人:M Javad Aman
-
依托单位:
Immunotherapy of MRSA Osteomyelitis
-
批准号:10253297
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2021
-
负责人:M Javad Aman
-
依托单位:
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection
-
批准号:10358530
-
项目类别:
-
资助金额:$72.75万
-
财政年份:2020
-
负责人:M Javad Aman
-
依托单位:
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection
-
批准号:10579199
-
项目类别:
-
资助金额:$66.36万
-
财政年份:2020
-
负责人:M Javad Aman
-
依托单位:
Monoclonal antibodies targeting novel sites of vulnerability in marburg virus glycoprotein
-
批准号:9977125
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2019
-
负责人:M Javad Aman
-
依托单位:
Serotype independent therapeutic vaccine for Streptococcus pneumoniae
-
批准号:9253551
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2017
-
负责人:M Javad Aman
-
依托单位:
Rationally Designed Pan-Ebolavirus Vaccine
-
批准号:10163786
-
项目类别:
-
资助金额:$88.67万
-
财政年份:2017
-
负责人:M Javad Aman
-
依托单位:
Evolution of anti-filovirus B cell responses and mechanisms of protection
-
批准号:9890991
-
项目类别:
-
资助金额:$73.86万
-
财政年份:2017
-
负责人:M Javad Aman
-
依托单位:
Rationally Designed Pan-Ebolavirus Vaccine
-
批准号:10816056
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2017
-
负责人:M Javad Aman
-
依托单位:
Broadly Protective Bispecific Antibodies for Treatment of Ebola Virus Disease
-
批准号:9044732
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2016
-
负责人:M Javad Aman
-
依托单位:
Multivalent Toxoid Vaccine for Prevention of S. aureus Invasive Diseases
-
批准号:8799801
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2015
-
负责人:M Javad Aman
-
依托单位:
Multivalent Toxoid Vaccine for Prevention of S. aureus Invasive Diseases
-
批准号:8991471
-
项目类别:
-
资助金额:$77.94万
-
财政年份:2015
-
负责人:M Javad Aman
-
依托单位:
Multivalent Toxoid Vaccine for Prevention of S. aureus Invasive Diseases
-
批准号:8881395
-
项目类别:
-
资助金额:$64.67万
-
财政年份:2014
-
负责人:M Javad Aman
-
依托单位:
Multivalent Toxoid Vaccine for recurrent Staphylococccus aureus disease
-
批准号:10441657
-
项目类别:
-
资助金额:$70.29万
-
财政年份:2014
-
负责人:M Javad Aman
-
依托单位:
Multivalent Toxoid Vaccine for recurrent Staphylococccus aureus disease
-
批准号:10591579
-
项目类别:
-
资助金额:$67.06万
-
财政年份:2014
-
负责人:M Javad Aman
-
依托单位:
Multi-specific Antibody Therapy by targeting S. aureus toxins and polysaccharides
-
批准号:8393072
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2012
-
负责人:M Javad Aman
-
依托单位:
海外基金